A single brain-derived neurotrophic factor infusion into the dorsomedial prefrontal cortex attenuates cocaine self-administration-induced phosphorylation of synapsin in the nucleus accumbens during early withdrawal by Sun, Wei-Lun et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2015 
A single brain-derived neurotrophic factor infusion into the 
dorsomedial prefrontal cortex attenuates cocaine self-
administration-induced phosphorylation of synapsin in the 
nucleus accumbens during early withdrawal 
Wei-Lun Sun 
Sarah A. Eisenstein 
Agnieszka Zelek-Molik 
Jacqueline F. McGinty 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Received: January 21, 2014; Revised: June 10, 2014; Accepted: July 12, 2014
© The Author 2015. Published by Oxford University Press on behalf of CINP.




This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any 
medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
research article
A Single Brain-Derived Neurotrophic Factor 
Infusion into the Dorsomedial Prefrontal Cortex 
Attenuates Cocaine Self-Administration-Induced 
Phosphorylation of Synapsin in the Nucleus 
Accumbens during Early Withdrawal
Wei-Lun Sun, PhD; Sarah A. Eisenstein, PhD; Agnieszka Zelek-Molik, PhD; 
Jacqueline F. McGinty, PhD
Department of Neurosciences and Neurobiology of Addiction Research Center, Medical University of 
South Carolina, Charleston, South Carolina, (Drs Sun and McGinty); Department of Psychiatry, Washington 
University, St Louis, MO (Dr Eisenstein); Department of Brain Biochemistry, Institute of Pharmacology, Polish 
Academy of Sciences, Krakow, Poland (Dr Zelek-Molik).
Correspondence: Jacqueline F. McGinty, PhD, Department of Neurosciences, Medical University of South Carolina, 173 Ashley Ave MSC 510, Charleston, 
SC 29425 (mcginty@musc.edu).
Abstract
Background: Dysregulation in the prefrontal cortex-nucleus accumbens pathway has been implicated in cocaine addiction. 
We have previously demonstrated that one intra-dorsomedial prefrontal cortex brain-derived neurotrophic factor (BDNF) 
infusion immediately following the last cocaine self-administration session caused a long-lasting inhibition of cocaine-
seeking and normalized the cocaine-induced disturbance of glutamate transmission in the nucleus accumbens after 
extinction and a cocaine prime. However, the molecular mechanism mediating the brain-derived neurotrophic factor effect 
on cocaine-induced alterations in extracellular glutamate levels is unknown.
Methods: In the present study, we determined the effects of brain-derived neurotrophic factor on cocaine-induced changes 
in the phosphorylation of synapsin (p-synapsin), a family of presynaptic proteins that mediate synaptic vesicle mobilization, 
in the nucleus accumbens during early withdrawal.
Results: Two hours after cocaine self-administration, p-synapsin Ser9 and p-synapsin Ser62/67, but not p-synapsin Ser603, were 
increased in the nucleus accumbens. At 22 hours, only p-synapsin Ser9 was still elevated. Elevations at both time points were 
attenuated by an intra-dorsomedial prefrontal cortex brain-derived neurotrophic factor infusion immediately after the end of 
cocaine self-administration. Brain-derived neurotrophic factor also reduced cocaine self-administration withdrawal-induced 
phosphorylation of the protein phosphatase 2A C-subunit, suggesting that brain-derived neurotrophic factor disinhibits 
protein phosphatase 2A C-subunit, consistent with p-synapsin Ser9 dephosphorylation. Further, co-immunoprecipitation 
demonstrated that protein phosphatase 2A C-subunit and synapsin are associated in a protein-protein complex that was 
reduced after 2 hours of withdrawal from cocaine self-administration and reversed by brain-derived neurotrophic factor.
Conclusions: Taken together, these findings demonstrate that brain-derived neurotrophic factor normalizes the cocaine self-
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neurotransmitter release or represent a compensatory neuroadaptation in response to the hypofunction within the prefrontal 
cortex-nucleus accumbens pathway during cocaine withdrawal.
Keywords: cocaine self-administration, immunoblotting, nucleus accumbens, phosphatase, synapsin
Introduction
Susceptibility to drug relapse and other addictive behaviors is 
thought to depend on long-term neuroadaptations in the meso-
cortico–basal ganglia circuitry (Koob et  al., 1997; Wang and 
McGinty, 1997; White and Kalivas, 2001). Within this network, 
attention has focused on the prefrontal cortex (PFC) projection 
to the nucleus accumbens (NAc), because disruption of gluta-
mate neurotransmission in this pathway by repeated cocaine 
exposure triggers relapse to drug-seeking (McFarland et  al., 
2003). Brain-derived neurotrophic factor (BDNF) is expressed in 
PFC-NAc neurons wherein it regulates presynaptic glutamate 
release. We have reported that a single BDNF infusion into dor-
somedial (dm) PFC immediately following the final session of 
cocaine self-administration (SA) restores normal extracellular 
levels of glutamate in the NAc after cocaine SA and suppresses 
persistent cocaine-seeking (Berglind et al., 2007, 2009). In search-
ing for potential mechanisms that underlie the ability of BDNF 
in the PFC to normalize glutamate transmission in the NAc, our 
attention became focused on synapsins for the following rea-
sons. First, synapsins are members of a family of BDNF-regulated 
presynaptic proteins that control neurotransmitter exocytosis 
by reversibly tethering synaptic vesicles to each other and to 
the actin cytoskeleton in a phosphorylation-dependent man-
ner (Benfenati et al., 1989: Jovanovic et al., 1996). Second, after 
stimulation, the facilitatory effect of BDNF on glutamate release 
is attenuated in mice lacking synapsins I and II (Jovanovic et al., 
2000). Third, BDNF increases the number of docked synaptic 
vesicles at the active zone of excitatory synapses, facilitating 
release probability (Tyler and Pozzo-Miller, 2001).
Synapsin I(a,b), II(a,b), and III regulate trafficking of synaptic 
vesicles between the reserve pool and the active pool in terminals 
that release different transmitters (Gitler et al., 2004a). Synapsin 
I has been associated with regulating synaptic vesicles traffick-
ing in GABAergic neurons (Baldelli et al., 2007), whereas synap-
sin IIa has been associated with synaptic vesicles trafficking in 
glutamatergic terminals (Gitler et al., 2004b, 2008). Synapsin III 
has been associated with synaptic vesicles trafficking in dopa-
mine terminals in the striatum (Kile et al., 2010). Further, in mice 
lacking all 3 synapsins, the ability to mobilize the reserve pool of 
synaptic vesicles and release dopamine from striatal terminals 
was diminished following a cocaine challenge (Venton et  al., 
2006). In synapsin I-II mutant mice, reductions in vGlut1, vGlut2, 
and glutamate reuptake were observed (Bogen et al., 2006, 2009), 
and in vGlut knockout mice, there was a decrease of synapsin 
I expression and fewer synaptic vesicles in several brain regions 
(Fremeau et  al., 2004). Mice with decreased synapsin I  and II 
expression are prone to epileptiform seizures due to depletion 
of the reserve synaptic vesicle pool and enhanced docking in the 
readily releasable pool of excitatory neurons (Rosahl et al., 1995). 
For these reasons and because of similar molecular weights of 
synapsins Ia, Ib, and IIa that make it difficult to discriminate 
them consistently by immunoblotting, we focused attention 
only on cocaine-induced changes in phosphorylation of synap-
sin I and IIa, collectively termed here p-synapsin.
Unphosphorylated synapsins bind to and tether small 
synaptic vesicles to the actin cytoskeleton in the pretermi-
nal reserve pool, whereas phosphorylation of synapsins at 
specific sites causes release of synaptic vesicles, enabling 
them to traffic from the reserve pool to the readily releasable 
pool, increasing the probability of action potential-dependent 
neurotransmitter release. For example, high-frequency stimu-
lation that evokes calcium-dependent glutamate release is 
associated with protein kinase A/calcium/calmodulin-depend-
ent kinase (CAMK-mediated) phosphorylation of Ser9 and 
CaMKII-mediated phosphorylation of Ser603 (Chi et al., 2001; 
Hilfiker et  al., 1999, 2005). At the termination of exocytotic 
release, protein phosphatase 2A (PP2A)-mediated dephospho-
rylation of CAMK sites restores synapsin binding to synaptic 
vesicles and tethering to the cytoskeleton in the reserve pool. 
In contrast, there is an inverse relationship between Ca++ influx 
and synapsin phosphorylation at Ser62/67 by extracellular 
signal-regulated kinase mitogen-activated protein (ERK MAP) 
kinase. High-frequency stimulation promotes transient ERK-
mediated phosphorylation of synapsin at Ser62/67 sites that 
inhibits posttetanic potentiation and is terminated by PP2B 
(calcineurin)-dependent dephosphorylation (Jovanovic et  al., 
2001; Vara et  al., 2009). However, low-frequency stimulation 
can promote phosphorylation of synapsin Ser62/67 (and Ser 
9), facilitating dissociation of synaptic vesicles from the actin 
cytoskeleton (Chi et  al., 2003). In addition, BDNF stimulates 
ERK/MAPK-mediated synapsin I Ser62/67 phosphorylation that 
augments glutamate release in cortical synaptosomes in a cal-
cium-independent manner (Jovanovic et al., 2000).
Based on this background, we first evaluated whether 
cocaine, in the presence or absence of intra-dmPFC BDNF 
infusion at the end of SA, affects the phosphorylation of 
synapsins at the 3 major phosphorylation sites during early 
withdrawal (2 or 22 hours after the end of the last session of 
cocaine SA). These are the time points at which a normalizing 
effect of BDNF on cocaine SA-induced changes in phospho-
ERK has been detected in both PFC and NAc (Berglind et al., 
2007; Whitfield et  al., 2011). Further, after determining that 
phosphorylation was altered by cocaine SA, we explored the 
possible association of PP2A with synapsin after cocaine SA 
and/or intra-dmPFC BDNF infusion.
Methods
Animals
Adult male Sprague-Dawley rats (Charles River, MA) weighing 
301 to 325 g at the beginning of each experiment were housed 
individually in a temperature- and humidity-controlled vivar-
ium on a reversed 12-h–light/–dark cycle (lights off at 7:00 am). 
Animals were given 20 to 25 g of standard rat chow (Harlan) 
with ad libitum access to water daily. Experimental procedures 
were performed during the dark cycle. All experimental proto-
cols were approved by the Institutional Animal Care and Use 
Committee of the Medical University of South Carolina and 
complied with the National Institute of Health Guide for the 
Care and Use of Laboratory Animals (NIH publication no. 80-23, 
revised 1996). All efforts were made to minimize animal suffer-









 School Library user on 28 O
ctober 2019
Sun et al. | 3
Surgery
Animals were given at least a 5-day acclimation period. On the 
day of surgery, rats were anesthetized with a mixture of ketamine 
(66 mg/kg, intraperitoneally; Vedco Inc) and xylazine (1.33 mg/kg, 
intraperitoneally; Lloyd Laboratories), respectively, followed by 
equithesin (0.5 mL/kg) and ketorolac (2 mg/kg; Sigma-Aldrich). 
A silastic catheter was implanted into the right jugular vein with 
the distal end threaded subcutaneously and exiting on the back 
to connect to an infusion harness (Instech Solomon) for intra-
venous infusions. Immediately after catheterization, rats were 
implanted with 28-gauge bilateral stainless-steel guide cannu-
lae (Plastics One) aimed 1 mm above the dmPFC infusion site. 
Coordinates used in the stereotaxic procedures were +3.0 mm 
anterior-posterior (AP), ±0.6 mm mediolateral, and −1.6 mm dor-
soventral from the dural surface (Paxinos and Watson, 2005). 
Guide cannulae were secured to the skull with dental cement 
and steel screws. Two 10-mm stylets (Plastics One) were placed 
into the guide cannulae following surgery to prevent blockage 
throughout the experiment. After surgeries, daily intravenous 
infusions of 0.1 mL of the antibiotics, Cefazolin (10 mg/mL; 
Schein Pharmaceuticals) or Timentin (2.4 mg/mL), and 0.1 mL of 
heparinized saline (100 U/mL; Elkins-Sinn) were administered 
during surgical recovery and throughout SA to maintain cath-
eter patency. Catheter patency was verified as needed with an 
intravenous infusion of 0.1 mL of methohexital sodium (10 mg/
mL; Eli Lilly), which produces a rapid loss of muscle tone.
Cocaine SA and Intracranial Infusion
After 5 days of recovery, rats were food restricted to 90% of their 
body weight and subjected to 2-hour daily cocaine or yoked-
saline SA sessions under a FR1 reinforcement schedule in 
standard operant conditioning chambers (MED Associates) for 
14 days after they reached 10 infusions per session for 3 consec-
utive days. Each chamber was equipped with 2 retractable levers 
(7 cm above floor) and a circular stimulus light above each lever. 
Tygon infusion lines within the spring leash were mounted to 
a balanced metal arm and attached to a liquid swivel (Instech 
Solomon). Before each session, the catheter was secured to the 
infusion line. Presses on the active lever resulted in a 2-sec-
ond cocaine hydrochloride (0.2 mg/50  µL/infusion; NIDA) infu-
sion via a computer-controlled pump. Cocaine infusions were 
paired with a 5-second illumination of a white stimulus light 
above the active lever and a tone (2 kHz, 15 dB above ambient 
noise) followed by a 20-second timeout period, during which 
additional responses on the active lever resulted in no pro-
grammed consequences. Responses on the inactive lever were 
recorded but had no consequence. For each session, rats had to 
self-administer at least 10 infusions to fulfill the maintenance 
criterion. Immediately after the end of the last SA session, BDNF 
(0.75 µg/side; R&D Systems) or its vehicle, phosphate buffered 
saline (pH = 7.4), was infused into the dmPFC. Each bilateral infu-
sion was administered through an injector (33 gauge; Plastics 
One) inserted into the guide cannula so that 1 mm of the injec-
tor length extended beyond the guide cannula. After a 2-minute 
infusion (0.25 μL/min), the injectors remained in the cannulae 
for 1 minute to allow complete diffusion. Rats were then directly 
placed into their home cages.
Immunoblotting
Two or 22 hours after infusions, rats were rapidly decapi-
tated and brains were removed and placed in a brain matrix 
(Braintree Scientific). Two-mm coronal slices at AP 2.7 to 0.7 ros-
tral to Bregma were cut, and the NAc was bilaterally punched 
and frozen at −80oC. Coronal slices were also cut through the 
PFC between AP 2.7 and 3.7 mm rostral to Bregma to visually 
identify cannula placements in the dmPFC (all placements were 
verified to be in anterior cingulate/prelimbic cortex) before 
freezing and immunoblotting of other proteins (Sun et  al., 
2013). Protein from NAc samples was extracted by sonication 
in ice-cold RIPA lysis buffer and centrifuged at 10 000  × g for 
20 minutes at 4°C. The resulting supernatants were collected 
and subjected to protein analysis with the Micro-Bicinchoninic 
Acid assay kit (Pierce, Rockford, IL). Equal amounts of protein 
extracts were run on SDS-PAGE gels and then transferred to 
PVDF membranes. Membranes were then blocked with 5% 
nonfat dry milk in Tris-buffered saline with Tween-20 (TBST; 
pH = 7.6) for 1 hour at room temperature and incubated with 
primary antibody against p-synapsin Ser9 recognizing all syn-
apsin isoforms at the Ser9 site (1:2000; Cell Signaling), p-synap-
sin I Ser62/67 (1:1000), p-synapsin I Ser603 (1:3000; Millipore), or 
p-PP2Ac Tyr307 (1:5000; Abcam) overnight at 4°C. After 3 washes 
with TBST, membranes were incubated with their appropriate 
secondary antibodies for 1 hour at room temperature followed 
by 3 more washes with TBST. Antibody binding was detected 
by using an enhanced chemiluminescence kit (ECL Plus; GE 
Healthcare Bio-Sciences). Membranes were then stripped and 
reprobed for total protein by antisera against synapsin (1:2000; 
Cell Signaling) or PP2Ac (1:5000; Millipore) for quantitation. 
Equal loading proteins were further confirmed by probing 
with anti-calnexin antiserum (1:10 000; Enzo Life Sciences). All 
Western-blot analyses were performed a minimum of twice 
and the data were averaged. The integrated density value of 
each phosphoprotein (phospho-synapsin Ia, Ib, and IIa Ser9 
measured together) and total protein band were measured 
using ImageJ software (NIH).
Co-Immunoprecipitation
The procedure of co-immunoprecipitation was previously 
described (Sun et  al., 2009). Briefly, equal amounts of protein 
extracts (250  µg) were pooled from 2 to 3 rats per group and 
incubated in RIPA lysis buffer containing antibody against total 
synapin (9  µg; Cell Signaling) or PP2Ac (8  µg; Millipore) over-
night, followed by the addition of protein A/G agarose beads 
(30 µL; Santa Cruz Technologies) for 4 hours at 4°C. Beads were 
then washed 4 times in the RIPA lysis buffer. After final centrifu-
gation, Lammeli buffer containing 1% β-mercaptoethanol was 
added, boiled for 5 minutes, loaded into gels, and analyzed by 
immunoblotting procedures as described above. Two percent of 
protein extract was used as input to normalize the protein band 
intensity.
Statistical Analysis
Two standard deviations from the mean were used to exclude 
potential outliers of each group. Independent t tests were used 
for the SA behavioral measurements. For biochemical data, 
2-way analysis of variances (ANOVAs) [treatment (saline vs 
cocaine) × infusion (vehicle vs BDNF)] were used followed by 
Student–Newman–Keuls (SNK) multiple comparison tests when 
a significant interaction or main effect was found after ANOVA. 
Because of the small sample size (3–5 samples/group), Fisher’s 
Least Significant Difference test was used to analyze the co-
immunoprecipitation data after ANOVA. The criterion for statis-
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Results
During the last 3 SA sessions, cocaine self-administering rats 
exhibited significantly lower inactive lever pressing and higher 
active lever pressing than yoked-saline controls, indicating the 
acquisition of cocaine-associated reinforcing effects (Table  1; 
2 hours: inactive lever: t29 = −3.31, P < .01; active lever: t29 = 10.53, 
P < .001; 22 hours: inactive lever: t23 = −4.10, P < .001; active lever: 
t23 = 7.66, P < .001). Before receiving intra-dmPFC vehicle or BDNF 
infusion, rats with the cocaine SA history pressed a similar 
amount on the active levers and received a similar number of 
cocaine infusions.
Two hours after intra-dmPFC infusions, there was a signifi-
cant treatment × infusion interaction for p-synapsin Ser9 in 
the NAc (F1,24 = 5.20, P < .05). A  SNK test revealed greater p-syn-
apsin Ser9 protein expression in the cocaine-/vehicle-treated 
group than in the saline-/vehicle- and cocaine-/BDNF-treated 
groups (P < .05) (Figure  1a). Similarly, for the protein expres-
sion of p-synapsin Ser62/67, there was a trend toward a main 
effect of treatment (F1,27 = 3.68, P = .07) with a significant treat-
ment × infusion interaction (F1,27 = 7.16, P < .05). The cocaine-/
vehicle-treated group alone had higher p-synapsin Ser62/67 
in the NAc than in other groups (P < .05) (Figure  1b). Neither 
cocaine nor BDNF altered p-synapsin Ser603 protein expression. 
Twenty-two hours after infusion, there was also a trend toward 
a main effect of infusion and a significant treatment × infusion 
interaction for p-synapsin Ser9 (F1,21 = 3.49, P = .08 and F1,21 = 5.01, 
P < .05, respectively) (Figure  2a). The SNK multiple comparison 
revealed that the protein expression of p-synapsin Ser9 was 
significantly greater in the cocaine/vehicle group than in other 
groups (P < .05). The protein levels of p-synapsin Ser62/67 and 
Ser603 were not changed 22 hours after infusion (Figure 2b and 
c). Further, there was no alteration in total synapsin expression 
at either time point examined.
PP2Ac is the protein phosphatase that dephosphorylates 
p-synapsin Ser9 (Jovanovic et  al., 2001). We further evalu-
ated p-PP2Ac Tyr307 (associated with inactivation of PP2A) 
protein levels due to the augmentation of p-synapsin Ser9 
in the NAc 2 and 22 hours after the end of cocaine SA. Two 
hours after infusion, 2-way ANOVA indicated that there was 
a significant main effect of treatment (F1,26 = 10.68, P < .01) and 
a treatment × infusion interaction (F1,26 = 10.03, P < .01). SNK 
multiple comparisons showed a higher p-PP2Ac Tyr307 pro-
tein induction in the cocaine/vehicle group than in other 
groups (P < .01) (Figure 3a). Similarly, 22 hours after infusion, 
there was a significant main effect of treatment t (F1,26 = 9.60, 
P < .05) with a treatment × infusion interaction (F1,26 = 5.28, 
P < .05). Further analysis indicated that the protein expres-
sion of p-PP2Ac in the cocaine-/vehicle-treated group was 
significantly increased compared with other groups (P < .01) 
(Figure 3b). The total PP2Ac protein levels were not altered at 
either time point examined.
Given that the modulatory effect of PP2Ac on synapsin may 
be through a protein-protein interaction, we further evaluated 
the possibility of an alteration in a PP2Ac:synapsin association 
after cocaine SA with or without BDNF infusion. First, an inter-
action between PP2Ac and synapsin was detected in the NAc of 
drug naïve rats (Figure 4a left). This protein-protein interaction 
was further confirmed using a reciprocal co-immunoprecipita-
tion approach: immunoprecipitation using PP2Ac antibody fol-
lowed by probing with the synapsin antibody (Figure 4a right). 
In the 2-hour time point samples, a 2-way ANOVA revealed a 
significant treatment × infusion interaction (F1,11 = 5.23, P < .05). 
Multiple comparison tests indicated that the PP2Ac:synapsin 
protein complex was significantly lower in the cocaine-/vehi-
cle-treated group than in saline-/vehicle- or cocaine-/BDNF-
treated groups (Fisher’s Least Significant Difference test; p < .05) 
(Figure 4b). No alteration of total PP2Ac as input was detected.
Discussion
In the present study, we demonstrated that p-synapsin Ser9 
was increased in the NAc after 2 and 22 hours of withdrawal 
from cocaine SA. Elevation of p-synapsin Ser62/67 was also 
observed in cocaine-treated rats, but only at the 2-hour time 
point. Phosphorylation of PP2Ac was significantly elevated 
(indicating inactivation) after cocaine SA at the 2 time points 
examined. This elevation and that of p-synapsin at both the 
Ser9 and Ser62/67 sites was normalized by intra-dmPFC BDNF 
infusion. Further, co-immunoprecipitation revealed a protein-
protein interaction between synapsin and PP2Ac in presynaptic 
terminals that cocaine reduced and intra-dmPFC BDNF infusion 
reversed.
These data indicate that during early withdrawal from 
cocaine SA, p-synapsin Ser9 is elevated due to a dissociation of 
PP2Ac from synapsin and a decrease in PP2A activity in presyn-
aptic terminals in the NAc. Intra-dmPFC BDNF reactivates PP2A, 
resulting in enhanced binding of PP2A to, and dephosphoryla-
tion of, p-synapsin Ser9 in NAc terminals. Although these ter-
minals likely originate from PFC neurons, indirect effects via 
the amygdala, for example, cannot be ruled out. Since PP2A also 
mediates the deactivation of CaMKI (DeRemer et al., 1992) and 
CAMKI is localized in the neuropil (Picciotto et al., 1995), future 
studies can focus on whether elevation of p-synapsin Ser9 is 
associated with a reduction of PP2A’s inhibitory effect on CaMKI 
in PFC-NAc terminals. Elevated p-synapsin Ser9 in NAc immedi-
ately after the last cocaine SA session using a different regimen 
(4-hour daily sessions) has been previously detected (Edwards 
et al., 2007), suggesting that changes in p-synapsin Ser9 expres-
sion are common time-dependent monitors of presynaptic plas-
ticity in NAc in response to cocaine SA.
 In contrast to the elevated p-synapsin Ser9 after 2 and 22 
hours of withdrawal from cocaine, an increase in ERK-mediated 
p-synapsin Ser62/67 was observed only at the 2-hour time point. 
Table 1. Average Number of Lever Presses and Cocaine Infusions during the Last 3 Sessions of SA
Group Treatment Inactive Lever Active Lever Cocaine Infusions
2 h Yoked-saline 4.19 ± 1.40 5.50 ± 1.23 —
Cocaine SA 0.40 ± 0.25* 35.31 ± 2.10* 27.49 ± 1.35
22 h Yoked-saline 3.81 ± 0.88 6.83 ± 1.45 —
Cocaine SA 0.26 ± 0.18* 35.13 ± 3.69* 28.92 ± 3.69
Abbreviation: SA, self-administration.
Data represent mean ± SEM of each group and sacrificed 2 or 22 h after the end of the last SA session (2 h: yoked-saline [N = 12], cocaine SA [N = 19]; 22 h: yoked-saline 
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The phosphorylation of ERK-mediated p-synapsin in response 
to low activity at 2 hours may be reversed as neuronal activ-
ity is restored and more Ca2+ influx triggers PP2B activation 
with time (22 hours). A similar upregulation of p-synapsin Ser9 
and downregulation of ERK-activated p-synapsin Ser62/67 has 
been documented after 4-aminopyridine induced Ca2+ influx 
(Jovanovic et al., 2001). Moreover, a decrease in phosphorylation 
of ERK and CREB in dmPFC was observed at 2 hours, but not after 
Figure 1. Effects of intra-dorsomedial (dm) prefrontal cortex (PFC) brain-derived neurotrophic factor (BDNF) infusion on p-synapsin protein expression in the nucleus 
accumbens (NAc) after 2 hours of withdrawal from cocaine self-administration (SA). (a) Top: Quantitative analysis of p-synapsin Ser9 protein levels in the NAc. Bottom: 
Representative immunoblots for p-synapsin Ser9 and t-synapsin from each group (SV: N = 6; SB: N = 6; CV: N = 8; CB: N = 8). (b) Top: Quantitative analysis of p-synapsin 
Ser62/67 protein levels in the NAc. Bottom: Representative subsections of an immunoblot for p-synapsin Ser62/67 and t-synapsin from each group (SV: N = 6; SB: N = 6; 
CV: N = 9; CB: N = 10). (c) Top: Quantitative analysis of p-synapsin Ser603 protein levels in the NAc. Bottom: Representative immunoblots illustrating bands of p-synapsin 
Ser603 and t-synapsin from each group (SV: N = 6; SB: N = 6; CV: N = 9; CB: N = 10). Bar graphs show the mean ± SEM of each group. *P < .05 vs SV; #P < .05 vs CB, 2-way analy-
sis of variance (ANOVA) followed by Student–Newman–Keuls (SNK) multiple comparisons. B, BDNF; C, cocaine; S, saline; V, vehicle.
Figure 2. Effects of intra-dorsomedial (dm) prefrontal cortex (PFC) brain-derived neurotrophic factor (BDNF) infusion on p-synapsin protein expression in the nucleus 
accumbens (NAc) after 22 hours of withdrawal from cocaine self-administration (SA). (a) Top: Quantitative analysis of p-synapsin Ser9 protein levels in the NAc. Bottom: 
Representative immunoblots for p-synapsin Ser9 and t-synapsin from each group (SV: N = 6; SB: N = 6; CV: N = 6; CB: N = 7). (b) Top: Quantitative analysis of p-synapsin 
Ser62/67 protein levels in the NAc. Bottom: Representative subsections of an immunoblot for p-synapsin Ser62/67 and t-synapsin from each group (SV: N = 6; SB: N = 6; 
CV: N = 6; CB: N = 7). (c) Top: Quantitative analysis of p-synapsin Ser603 protein levels in the NAc. Bottom: Representative immunoblots illustrating bands of p-synapsin 
Ser603 and t-synapsin from each group (SV: N = 6; SB: N = 6; CV: N = 6; CB: N = 7). Bar graphs show the mean ± SEM of each group. *P < .05 vs SV; #P < .05 vs CB, 2-way analysis 
of variance (ANOVA) followed by Student–Newman–Keuls (SNK) multiple comparison. B, BDNF; C, cocaine; S, saline; V, vehicle.
Figure 3. Intra-dorsomedial (dm) prefrontal cortex (PFC) brain-derived neurotrophic factor (BDNF) infusion suppresses p-PP2Ac Tyr307 protein induction in the nucleus 
accumbens (NAc) after cocaine self-administration (SA). (a) Top: Quantitative analysis of p-PP2Ac Tyr307 protein levels in the NAc 2 hours after the end of cocaine SA. 
Bottom: Representative immunoblots for p-PP2Ac Tyr307 and t-PP2Ac from each group (SV: N = 6; SB: N = 6; CV: N = 8; CB: N = 10). (b) Top: Statistical analysis of p-PP2Ac 
Tyr307 protein levels in the NAc after 22 hours of withdrawal from cocaine SA. Bottom: Representative immunoblots illustrating bands of p-PP2Ac Tyr307 and t-PP2Ac 
from each group (SV: N = 6; SB: N = 6; CV: N = 7; CB: N = 6). Histograms show the mean ± SEM of each group. *P < .05 vs SV; #P < .05 vs CB, 2-way analysis of variance (ANOVA) 
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22 hours, of abstinence from cocaine SA (Whitfield et al., 2011), 
suggesting a gradual recovery of neuronal activity in the PFC as 
the phase of withdrawal changes. Therefore, the dynamic altera-
tion of p-synapsin 62/67 in the NAc may represent a sensitive 
biomarker of PFC neuronal activity changes. Because CaMK- and 
ERK-mediated phosphorylation of synapsin play different roles 
in modulating the tethering of synaptic vehicles to the actin 
cytoskeleton (Huttner et  al., 1983; Sihra et  al., 1989; Jovanovic 
et al., 1996; Hosaka et al., 1999), differential regulation of their 
phosphorylation states in the NAc is likely to have a function-
ally significant impact on synaptic transmission after cocaine 
SA ends.
The differential phosphorylation of synapsin sites by cocaine 
in this study may reflect compensatory responses and be related 
to other findings that basal cortical hypoactivity and sensitized 
responses to evoked activity occur during early withdrawal from 
cocaine. First, dephosphorylation of ERK and CREB in the dmPFC 
(Whitfield et al., 2011) is accompanied by the attenuated phos-
phorylation of striatal-enriched protein tyrosine phosphatase 
and its targets, GluN1/2B, in the dmPFC after 2 hours of absti-
nence from cocaine SA (Sun et al., 2013). Increased phosphatase 
activity and decreased glutamatergic transmission may indicate 
synaptic depression in the PFC as a critical part of the with-
drawal cascade. Second, basal extracellular glutamate levels in 
the NAc are similarly reduced after 1, 21, or 60 days of cocaine 
SA abstinence (Lutgen et al., 2014; Wydra et al., 2013), but a spe-
cific enhancement of evoked release probability at PFC-NAc 
synapses occurs after 1  day of abstinence (Suska et  al., 2013) 
and excessive evoked glutamate release occurs in response 
to cocaine prime-induced reinstatement after extinction 
(McFarland et al., 2003). Third, basal electrophysiological activity 
in the PFC of rats is suppressed, but stimulus-evoked burst dura-
tion and firing rate are enhanced within 24 hours after the end 
of cocaine SA (Sun and Rebec, 2006). Fourth, downregulation of 
immediate early gene and Bdnf mRNA occurs within 22 hours of 
cocaine withdrawal, but robust upregulation occurs in response 
to cue-induced relapse to drug-seeking (Hearing et  al., 2008; 
McGinty et al., 2010). Finally, basal hypoactivity punctuated by 
hyper-responsiveness of PFC to cues associated with cocaine are 
critical disturbances in abstinent human cocaine addicts that 
are associated with craving and relapse (Childress et al., 1999; 
Goldstein and Volkow, 2011). Thus, it is possible that by repeat-
edly driving synaptic activity and excessive glutamate release 
in NAc (Miguens et  al., 2008), cocaine SA causes hyper-phos-
phorylation of synapsins and depletion of the reserve SV pool 
along with increased evoked release probability that extends 
into withdrawal.
The mechanism underlying the ability of a BDNF infusion 
into dmPFC to normalize synapsin and PP2Ac phosphorylation 
in the NAc during early withdrawal is likely related to BDNF’s 
ability to increase synaptic activity. Emerging evidence indicates 
that inhibition of synaptic activity in the PFC blocks the ability 
of intra-PFC BDNF to suppress cocaine-seeking (Go and McGinty, 
2013). In addition, BDNF has been demonstrated to increase 
excitatory glutamatergic neuronal activity (Haubensak et  al., 
1998) as well as PP2A activity in cortical neurons (Jovanovic 
et al., 2004). Sustained depolarization also increases PP2A activ-
ity in midbrain dopamine neurons (Padmanabhan and Prasad, 
2009). Thus, it is possible that intra-dmPFC BDNF infusion acti-
vates PP2A/PP2B and normalizes p-synapsin Ser9 and Ser62/67 
levels and restores the cocaine-depleted reserve pool of syn-
aptic vesicles in NAc terminals as a function of restoring PFC 
neuronal activity during early withdrawal. Future studies will 
attempt to extend and confirm this hypothesis by establishing 
whether cocaine SA depletes, and BDNF restores, the reserve 
pool of SVs in the NAc and the possible underlying mechanisms.
Surprisingly, in the NAc of yoked-saline animals, we did not 
observe any p-synapsin changes after intra-dmPFC BDNF infu-
sion, which is in contrast to a previous study demonstrating the 
elevation of p-synapsin in the synaptosomal fraction induced 
by local BDNF application (Jovanovic et al., 2010). Because total 
homogenates of NAc were used and BDNF was infused in the 
dmPFC in the present study, the underlying mechanism of BDNF 
effects on the local axon terminals in the NAc could not be 
examined in detail, which may partially explain the discrepancy. 
Further experiments using synapsomal and/or presynaptic frac-
tions are needed to elucidate BDNF’s effects on p-synapsin and 
its upstream activators as well as other possible alternative 
intracellular mechanisms.
In conclusion, we demonstrated both p-synapsin Ser9 and 
Ser62/67 in the NAc were induced during early withdrawal 
Figure  4. Intra-dorsomedial (dm) prefrontal cortex (PFC) brain-derived neuro-
trophic factor (BDNF) infusion normalizes the reduction of PP2A:synapsin I bind-
ing in the nucleus accumbens (NAc) after cocaine self-administration (SA). (a) 
A control experiment shows images of specificity for PP2A and synapsin binding 
in the NAc from drug naïve rats. Left: Representative images of NAc homoge-
nates immunoprecipitated by t-synapsin followed by probing with t-synapsin 
and t-PP2Ac antibodies. Right: Immunoblots illustrating the bands of t-synapsin 
I and t-PP2Ac after t-PP2Ac antibody immunoprecipitation. (b) Top: Quantitative 
analysis of PP2Ac:synapsin protein binding levels in the NAc 2 hours after the 
end of cocaine SA. Bottom: Representative bands of an immunoblot of t-PP2Ac 
and its input protein levels after immunoprecipitation by t-synapsin antibody 
from each group (SV: N = 3; SB: N = 3; CV: N = 4; CB: N = 5). Histograms show the 
mean ± SEM of each group. *P < .05 vs SV; #P < .05 vs CB, 2-way analysis of vari-
ance (ANOVA) followed by Fisher’s Least Significant Difference (LSD) multiple 
comparison. B, BDNF; C, cocaine; CNXN, calnexin; IB, immunoblotting; IP, immu-









 School Library user on 28 O
ctober 2019
Sun et al. | 7
from cocaine SA. This hyper-phosphorylation of synapsins 
may represent a molecular disturbance of the reserve pool of 
synaptic vesicles that contributes to synaptic depression and 
alters release probability in the PFC-NAc pathway during with-
drawal from cocaine SA. However, the possible contribution of 
PFC-amygdala-NAc input on synapsin phosphorylation cannot 
be excluded, since BDNF was elevated in the amygdala after 
intra-dmPFC BDNF infusion (McGinty et al., 2010). Nevertheless, 
together with our previous findings (Berglind et al., 2007, 2009; 
Whitfield et al., 2011), the ability of intra-dmPFC BDNF infusion 
to rescue p-synapsin in the NAc and related signaling cascades 
in the PFC suggests that the restoration of PFC function during 
early withdrawal may abrogate maladaptive responses that dis-
turb the PFC output to the NAc. Therefore, the BDNF/TrkB sys-
tem in the PFC-NAc pathway remains a potential therapeutic 
target for early intervention in cocaine addiction.
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